Literature DB >> 28260596

Robotic-assisted laparoscopic hysterectomy for women with endometrial cancer.

Suzanne Forsyth Herling1, Ann M Møller, Connie Palle, Anja Grynnerup, Thordis Thomsen.   

Abstract

INTRODUCTION: Robotic-assisted laparoscopic hysterectomy (RALH) has become a widely used approach for women with endometrial cancer and has replaced laparotomy. It has been questioned if the increased costs are justified by superior surgical outcomes. The aim of the present study was to examine the frequency, types and severity of post-operative complications after total abdominal hysterectomy (TAH) and RALH using the Clavien-Dindo classification of surgical outcomes.
METHODS: A non-randomised, controlled before and after study of 360 women was conducted; 202 underwent RALH and 158 TAH (historical controls).
RESULTS: RALH had significant advantages compared with TAH: fewer and less severe post-operative complications and a shorter length of hospital stay. The absolute risk reduction for post-operative complications was 13% (95% confidence interval: 4.29-20.87%). Women treated with TAH had significantly more severe complications (grade ≥ 3) than those treated with RALH; 12% versus 3% (p = 0.001). Infections (urinary and port site) were the most frequent post-operative complications overall. The duration of RALH in the operation theatre was longer, while the duration of stay in the post-anaesthesia care unit was shorter for patients undergoing RALH.
CONCLUSIONS: RALH appears advantageous for women treated for endometrial cancer in terms of post-operative complications. We recommend the use of the Clavien-Dindo classification of surgical outcomes for quality assessment. FUNDING: departmental only. TRIAL REGISTRATION: Danish Health Authority (3-2013-111/1/KAHO).

Entities:  

Mesh:

Year:  2017        PMID: 28260596

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  1 in total

1.  Robot-Assisted Total Laparoscopic Hysterectomy in Different Classes of Obesity: A Cohort Study.

Authors:  Ilse Haveman; Willem Jan van Weelden; Elisabeth A Roovers; Arjan A Kraayenbrink; F Paul H L J Dijkhuizen
Journal:  JSLS       Date:  2022 Jan-Mar       Impact factor: 1.789

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.